Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Viridian Therapeutics Inc (VRDN)

15.37   -0.36 (-2.29%) 04-14 06:05
Open: 15.27 Pre. Close: 15.73
High: 16 Low: 15.27
Volume: 13,697 Market Cap: 111M
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody for the treatment of thyroid eye disease; VRDN-002, a biosuperior IGF-1R antibody; and VRDN-003, an IGF-1R antibody product specifically designed for thyroid eye disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is based in Boulder, Colorado.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 16.02 - 16.098 16.098 - 16.175
Low: 15.046 - 15.141 15.141 - 15.235
Close: 15.193 - 15.344 15.344 - 15.494

Technical analysis

as of: 2021-04-13 5:06:48 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 20.24     One year: 22.06
Support: Support1: 14.80    Support2: 12.31
Resistance: Resistance1: 17.33    Resistance2: 18.89
Pivot: 16.66
Moving Average: MA(5): 16.10     MA(20): 17.02
MA(100): 16.05     MA(250):
MACD: MACD(12,26): -0.47     Signal(9): -0.29
Stochastic oscillator: %K(14,3): 20.38     %D(3): 31.89
RSI: RSI(14): 39.34
52-week: High: 25.19  Low: 8.40  Change(%): -7.7
Average Vol(K): 3-Month: 6836  10-Days: 2407

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
VRDN has closed above bottom band by 12.3%. Bollinger Bands are 39.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 07 Apr 2021
Do Institutions Own Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares? - Simply Wall St

Thu, 25 Mar 2021
Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates - GlobeNewswire

Thu, 18 Mar 2021
Will Viridian Therapeutics, Inc. (VRDN) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance

Tue, 09 Mar 2021
Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update - GlobeNewswire

Wed, 03 Mar 2021
Will Viridian Therapeutics, Inc. (VRDN) Report Negative Q4 Earnings? What You Should Know - Nasdaq

Mon, 22 Feb 2021
Reflecting on Viridian Therapeutics' (NASDAQ:VRDN) Share Price Returns Over The Last Three Years - Yahoo Finance

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Neutral
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 7
Shares Float (M) 5
% Held by Insiders 4.55
% Held by Institutions 49.55
Shares Short (K) 121
Shares Short P. Month (K) 151

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin -3830.38
Return on Assets (ttm) -31.1
Return on Equity (ttm) -163.1
Qtrly Rev. Growth -93.9
Gross Profit (p.s.) -3.728
Sales Per Share 0.145
EBITDA (p.s.) -5.530
Qtrly Earnings Growth
Operating Cash Flow (M) -30
Levered Free Cash Flow (M) -16

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 105.83
Price to Cash Flow -3.73

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date 2020-11-12
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.